An Ankylosing Spondylitis (AS) Case Report (2010)

To illustrate the efficacy of medicinal Thunder God Vine (mTGV) in Ankylosing Spondylitis, this report is quite interesting. Not because of the number of patients that was really small, but because of the Introduction of the study which describes with many details the use of mTGV in Ankylosing Spondylitis since the 1980s.

mTGV = medicinal Thunder God Vine = Tripterygium wilfordii Hook F = TwHF = Lei Gong Teng

Download the full study for free:

Quoting the case report

” T. wilfordii in tablet forms (mTGV) have been approved by the China State Food and Drug Administration for use in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and ankylosing spondylitis (AS)…”

“Chinese language database showed that the earliest report of the use of T. wilfordii in AS was in 1981. Since then, at least four other Chinese language papers have been published, comprising a total of 175 AS patients. The efficacy of T. wilfordii was broadly described as being nearly 90% effective.”

Medicinal Thunder God Vine is an established treatment in Ankylosing Spondylitis

Medicinal Thunder God Vine is approved and a common Ankylosing Spondylitis natural treatment in China. It’s a natural immunosuppressant that is both safe and usually very efficient in AS, with a history of 30 years prescription.

Other notes

Regarding the studies the report cites, that have never been translated in other languages: The reason the report says, is “…none of these Chinese language papers assessed patients with internationally standardized evaluation instruments.”

Basically, it means that these studies were designed with Chinese standards which are different and don’t comply with Western design standards. Reason why they will never be available in international medical publications. China has its own ways.

The report is not assessing much in itself, but it raises the interest regarding the superiority of mTGV in AS, compared to other treatments that are usually not as effective or safe. And also of the side effects that are common on the reproductive system.